Several interventions for tuberculosis (TB) control have been recommended by the World Health Organization (WHO) over the past decade. These include isoniazid preventive therapy (IPT) for HIV-infected individuals and household contacts of infectious TB patients, diagnostic algorithms for rule-in or rule-out of smear-negative pulmonary TB, and programmatic treatment for multidrug-resistant TB. There is no systematically collected data on the type of evidence that is publicly available to guide the scale-up of these interventions in low- and middle-income countries. We investigated the availability of published evidence on their effectiveness, delivery, and cost-effectiveness that policy makers need for scaling-up these interventions at count...
Tuberculosis is over-represented in hard-to-reach (underserved) populations in high-income countries...
Contains fulltext : 49179.pdf (publisher's version ) (Open Access)OBJECTIVE: To as...
SETTING Drug resistance threatens tuberculosis (TB) control, particularly among human immunodefic...
Several interventions for tuberculosis (TB) control have been recommended by the World Health Organi...
© 2016 Charles et al. This is an open access article distributed under the terms of the Creative Com...
Tuberculosis (TB) is a leading cause of death in developing countries and an important health threat...
Tuberculosis is among the top ten causes of global mortality and affects low-income countries in par...
AIMS: What is the evidence base for the effectiveness of interventions to reduce tuberculosis (TB) i...
Poverty drives tuberculosis (TB) rates but the approach to TB control has been disproportionately bi...
CONTEXT: Poor adherence to treatment remains a major obstacle to efficient tuberculosis (TB) control...
The treatment of tuberculosis (TB) is ranked as the most cost effective of all therapeutic programme...
textabstractTuberculosis (TB) is a leading cause of death in developing countries and an important h...
Item does not contain fulltextTuberculosis (TB) is a leading cause of death in developing countries ...
BACKGROUND: Health care associated transmission of Mycobacterium tuberculosis (TB) is well described...
The international community has committed to ending the tuberculosis (TB) epidemic by 2030. This wil...
Tuberculosis is over-represented in hard-to-reach (underserved) populations in high-income countries...
Contains fulltext : 49179.pdf (publisher's version ) (Open Access)OBJECTIVE: To as...
SETTING Drug resistance threatens tuberculosis (TB) control, particularly among human immunodefic...
Several interventions for tuberculosis (TB) control have been recommended by the World Health Organi...
© 2016 Charles et al. This is an open access article distributed under the terms of the Creative Com...
Tuberculosis (TB) is a leading cause of death in developing countries and an important health threat...
Tuberculosis is among the top ten causes of global mortality and affects low-income countries in par...
AIMS: What is the evidence base for the effectiveness of interventions to reduce tuberculosis (TB) i...
Poverty drives tuberculosis (TB) rates but the approach to TB control has been disproportionately bi...
CONTEXT: Poor adherence to treatment remains a major obstacle to efficient tuberculosis (TB) control...
The treatment of tuberculosis (TB) is ranked as the most cost effective of all therapeutic programme...
textabstractTuberculosis (TB) is a leading cause of death in developing countries and an important h...
Item does not contain fulltextTuberculosis (TB) is a leading cause of death in developing countries ...
BACKGROUND: Health care associated transmission of Mycobacterium tuberculosis (TB) is well described...
The international community has committed to ending the tuberculosis (TB) epidemic by 2030. This wil...
Tuberculosis is over-represented in hard-to-reach (underserved) populations in high-income countries...
Contains fulltext : 49179.pdf (publisher's version ) (Open Access)OBJECTIVE: To as...
SETTING Drug resistance threatens tuberculosis (TB) control, particularly among human immunodefic...